Methylation profiling identifies epigenetic markers for high-grade gliomas

Andreas Waha, Fausto J. Rodrigues, Anke Waha, Birgit Meyer-Puttlitz, Webster K. Cavenee, Hui-ming Huang, Otmar D. Wiestler, Pearlly S. Yan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hypermethylation of CpG island is an epigenetic event prevalent in human gliomas. Here we employed a high-throughput microarray approach for a global search of DNA methylation to identify novel epigenetic loci in specific glioma subtypes. Hierarchical clustering analysis separated 20 glioma samples according to their WHO histopathological subtypes - pilocytic astrocytomas (PAs, grade I), oligoastrocytomas (OAs, grade II) and glioblastomas (GBMs, grade IV), based on their unique methylation patterns. The overall methylation frequency of the lowgrade PAs was significantly less than that of the more aggressive OAs and GBMs (0.45% versus 2.0% and 1.4%; PAs versus OAs, p0.01; PAs versus GBMs, p0.01). The lower level of DNA methylation observed in PAs may be in part due to the increased methylation of multiple CpG islands which occur in more advanced tumors. However, the young age of onset of PAs may also contribute to this observed difference. Although there were many hypermethylated loci exclusive to the OA and GBM subtypes, the methylation frequencies between these groups were not significantly different. Analysis by methylation-specific PCR on an expanded set of samples and on more glioma subtypes further confirmed an epigenetic marker, SMARCA5, the hypermethylation of which was preferentially observed in grade IV, but not in grades I or II gliomas (p0.0001). The intermediate grade III gliomas showed low levels of SMARCA5 hypermethylation. Epigenetic loci uncovered in the present study recapitulate the histopathological differences of these gliomas, indicating that these molecular changes may be responsible for the development of the different glioma subtypes. On-going work in our laboratory has shown that some of these loci are indeed hypermethylated in the early stages of astrocytic tumors.

Original languageEnglish (US)
Pages (from-to)209-214
Number of pages6
JournalCancer Genomics and Proteomics
Volume1
Issue number3
StatePublished - May 2004
Externally publishedYes

Fingerprint

Methylation
Epigenomics
Glioma
CpG Islands
Tumors
DNA Methylation
Microarrays
Throughput
Astrocytoma
Glioblastoma
Age of Onset
Cluster Analysis
Neoplasms
Polymerase Chain Reaction

Keywords

  • CpG island microarray
  • Differential methylation hybridization
  • DNA methylation
  • Gliomas
  • SMARCA5

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Cancer Research
  • Biochemistry

Cite this

Waha, A., Rodrigues, F. J., Waha, A., Meyer-Puttlitz, B., Cavenee, W. K., Huang, H., ... Yan, P. S. (2004). Methylation profiling identifies epigenetic markers for high-grade gliomas. Cancer Genomics and Proteomics, 1(3), 209-214.

Methylation profiling identifies epigenetic markers for high-grade gliomas. / Waha, Andreas; Rodrigues, Fausto J.; Waha, Anke; Meyer-Puttlitz, Birgit; Cavenee, Webster K.; Huang, Hui-ming; Wiestler, Otmar D.; Yan, Pearlly S.

In: Cancer Genomics and Proteomics, Vol. 1, No. 3, 05.2004, p. 209-214.

Research output: Contribution to journalArticle

Waha, A, Rodrigues, FJ, Waha, A, Meyer-Puttlitz, B, Cavenee, WK, Huang, H, Wiestler, OD & Yan, PS 2004, 'Methylation profiling identifies epigenetic markers for high-grade gliomas', Cancer Genomics and Proteomics, vol. 1, no. 3, pp. 209-214.
Waha A, Rodrigues FJ, Waha A, Meyer-Puttlitz B, Cavenee WK, Huang H et al. Methylation profiling identifies epigenetic markers for high-grade gliomas. Cancer Genomics and Proteomics. 2004 May;1(3):209-214.
Waha, Andreas ; Rodrigues, Fausto J. ; Waha, Anke ; Meyer-Puttlitz, Birgit ; Cavenee, Webster K. ; Huang, Hui-ming ; Wiestler, Otmar D. ; Yan, Pearlly S. / Methylation profiling identifies epigenetic markers for high-grade gliomas. In: Cancer Genomics and Proteomics. 2004 ; Vol. 1, No. 3. pp. 209-214.
@article{e2cfa5bd383646038a1a56fe284bb172,
title = "Methylation profiling identifies epigenetic markers for high-grade gliomas",
abstract = "Hypermethylation of CpG island is an epigenetic event prevalent in human gliomas. Here we employed a high-throughput microarray approach for a global search of DNA methylation to identify novel epigenetic loci in specific glioma subtypes. Hierarchical clustering analysis separated 20 glioma samples according to their WHO histopathological subtypes - pilocytic astrocytomas (PAs, grade I), oligoastrocytomas (OAs, grade II) and glioblastomas (GBMs, grade IV), based on their unique methylation patterns. The overall methylation frequency of the lowgrade PAs was significantly less than that of the more aggressive OAs and GBMs (0.45{\%} versus 2.0{\%} and 1.4{\%}; PAs versus OAs, p0.01; PAs versus GBMs, p0.01). The lower level of DNA methylation observed in PAs may be in part due to the increased methylation of multiple CpG islands which occur in more advanced tumors. However, the young age of onset of PAs may also contribute to this observed difference. Although there were many hypermethylated loci exclusive to the OA and GBM subtypes, the methylation frequencies between these groups were not significantly different. Analysis by methylation-specific PCR on an expanded set of samples and on more glioma subtypes further confirmed an epigenetic marker, SMARCA5, the hypermethylation of which was preferentially observed in grade IV, but not in grades I or II gliomas (p0.0001). The intermediate grade III gliomas showed low levels of SMARCA5 hypermethylation. Epigenetic loci uncovered in the present study recapitulate the histopathological differences of these gliomas, indicating that these molecular changes may be responsible for the development of the different glioma subtypes. On-going work in our laboratory has shown that some of these loci are indeed hypermethylated in the early stages of astrocytic tumors.",
keywords = "CpG island microarray, Differential methylation hybridization, DNA methylation, Gliomas, SMARCA5",
author = "Andreas Waha and Rodrigues, {Fausto J.} and Anke Waha and Birgit Meyer-Puttlitz and Cavenee, {Webster K.} and Hui-ming Huang and Wiestler, {Otmar D.} and Yan, {Pearlly S.}",
year = "2004",
month = "5",
language = "English (US)",
volume = "1",
pages = "209--214",
journal = "Cancer Genomics and Proteomics",
issn = "1109-6535",
publisher = "International Institute of Anticancer Research",
number = "3",

}

TY - JOUR

T1 - Methylation profiling identifies epigenetic markers for high-grade gliomas

AU - Waha, Andreas

AU - Rodrigues, Fausto J.

AU - Waha, Anke

AU - Meyer-Puttlitz, Birgit

AU - Cavenee, Webster K.

AU - Huang, Hui-ming

AU - Wiestler, Otmar D.

AU - Yan, Pearlly S.

PY - 2004/5

Y1 - 2004/5

N2 - Hypermethylation of CpG island is an epigenetic event prevalent in human gliomas. Here we employed a high-throughput microarray approach for a global search of DNA methylation to identify novel epigenetic loci in specific glioma subtypes. Hierarchical clustering analysis separated 20 glioma samples according to their WHO histopathological subtypes - pilocytic astrocytomas (PAs, grade I), oligoastrocytomas (OAs, grade II) and glioblastomas (GBMs, grade IV), based on their unique methylation patterns. The overall methylation frequency of the lowgrade PAs was significantly less than that of the more aggressive OAs and GBMs (0.45% versus 2.0% and 1.4%; PAs versus OAs, p0.01; PAs versus GBMs, p0.01). The lower level of DNA methylation observed in PAs may be in part due to the increased methylation of multiple CpG islands which occur in more advanced tumors. However, the young age of onset of PAs may also contribute to this observed difference. Although there were many hypermethylated loci exclusive to the OA and GBM subtypes, the methylation frequencies between these groups were not significantly different. Analysis by methylation-specific PCR on an expanded set of samples and on more glioma subtypes further confirmed an epigenetic marker, SMARCA5, the hypermethylation of which was preferentially observed in grade IV, but not in grades I or II gliomas (p0.0001). The intermediate grade III gliomas showed low levels of SMARCA5 hypermethylation. Epigenetic loci uncovered in the present study recapitulate the histopathological differences of these gliomas, indicating that these molecular changes may be responsible for the development of the different glioma subtypes. On-going work in our laboratory has shown that some of these loci are indeed hypermethylated in the early stages of astrocytic tumors.

AB - Hypermethylation of CpG island is an epigenetic event prevalent in human gliomas. Here we employed a high-throughput microarray approach for a global search of DNA methylation to identify novel epigenetic loci in specific glioma subtypes. Hierarchical clustering analysis separated 20 glioma samples according to their WHO histopathological subtypes - pilocytic astrocytomas (PAs, grade I), oligoastrocytomas (OAs, grade II) and glioblastomas (GBMs, grade IV), based on their unique methylation patterns. The overall methylation frequency of the lowgrade PAs was significantly less than that of the more aggressive OAs and GBMs (0.45% versus 2.0% and 1.4%; PAs versus OAs, p0.01; PAs versus GBMs, p0.01). The lower level of DNA methylation observed in PAs may be in part due to the increased methylation of multiple CpG islands which occur in more advanced tumors. However, the young age of onset of PAs may also contribute to this observed difference. Although there were many hypermethylated loci exclusive to the OA and GBM subtypes, the methylation frequencies between these groups were not significantly different. Analysis by methylation-specific PCR on an expanded set of samples and on more glioma subtypes further confirmed an epigenetic marker, SMARCA5, the hypermethylation of which was preferentially observed in grade IV, but not in grades I or II gliomas (p0.0001). The intermediate grade III gliomas showed low levels of SMARCA5 hypermethylation. Epigenetic loci uncovered in the present study recapitulate the histopathological differences of these gliomas, indicating that these molecular changes may be responsible for the development of the different glioma subtypes. On-going work in our laboratory has shown that some of these loci are indeed hypermethylated in the early stages of astrocytic tumors.

KW - CpG island microarray

KW - Differential methylation hybridization

KW - DNA methylation

KW - Gliomas

KW - SMARCA5

UR - http://www.scopus.com/inward/record.url?scp=33748743742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748743742&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 209

EP - 214

JO - Cancer Genomics and Proteomics

JF - Cancer Genomics and Proteomics

SN - 1109-6535

IS - 3

ER -